PL366639A1 - Heterocykliloalkoksy-,-alkilotio-i-alkiloaminobenzazolowe pochodne jako ligandy 5-hydroksytryptaminy-6 - Google Patents
Heterocykliloalkoksy-,-alkilotio-i-alkiloaminobenzazolowe pochodne jako ligandy 5-hydroksytryptaminy-6Info
- Publication number
- PL366639A1 PL366639A1 PL02366639A PL36663902A PL366639A1 PL 366639 A1 PL366639 A1 PL 366639A1 PL 02366639 A PL02366639 A PL 02366639A PL 36663902 A PL36663902 A PL 36663902A PL 366639 A1 PL366639 A1 PL 366639A1
- Authority
- PL
- Poland
- Prior art keywords
- alkylaminobenzazole
- heterocyclylalkoxy
- hydroxytryptamine
- alkylthio
- ligands
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/06—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28564401P | 2001-04-20 | 2001-04-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL366639A1 true PL366639A1 (pl) | 2005-02-07 |
Family
ID=23095117
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL02366639A PL366639A1 (pl) | 2001-04-20 | 2002-04-19 | Heterocykliloalkoksy-,-alkilotio-i-alkiloaminobenzazolowe pochodne jako ligandy 5-hydroksytryptaminy-6 |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US6831094B2 (pl) |
| EP (1) | EP1392682A2 (pl) |
| JP (1) | JP2004526781A (pl) |
| KR (1) | KR20030088507A (pl) |
| CN (1) | CN1293073C (pl) |
| AR (1) | AR034588A1 (pl) |
| AU (1) | AU2002309585B2 (pl) |
| BR (1) | BR0209047A (pl) |
| CA (1) | CA2444036A1 (pl) |
| EA (1) | EA200301143A1 (pl) |
| HU (1) | HUP0303801A2 (pl) |
| IL (1) | IL158448A0 (pl) |
| MX (1) | MXPA03009490A (pl) |
| NO (1) | NO20034647L (pl) |
| PL (1) | PL366639A1 (pl) |
| WO (1) | WO2002085853A2 (pl) |
| ZA (1) | ZA200309009B (pl) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA04012122A (es) * | 2002-06-05 | 2005-04-19 | Hoffmann La Roche | Derivados de 1-sulfonil-4-aminoalcoxi indol como moduladores del receptor 5-hidroxitriptamina 6 (5-5-ht6) para tratamiento de trastornos del sistema nervioso central (snc). |
| PL377464A1 (pl) * | 2002-12-03 | 2006-02-06 | F. Hoffmann-La Roche Ag | Aminoalkoksyindole jako ligandy receptora 5-HT6 do leczenia zaburzeń OUN |
| WO2004074243A2 (en) * | 2003-02-14 | 2004-09-02 | Wyeth | Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands |
| SE0302760D0 (sv) * | 2003-10-20 | 2003-10-20 | Biovitrum Ab | New compounds |
| RU2429231C2 (ru) * | 2005-08-15 | 2011-09-20 | Вайет | Производные замещенного-3-сульфонилиндазола в качестве лигандов 5-гидрокситриптамина-6 |
| MX2008002158A (es) * | 2005-08-15 | 2008-04-19 | Wyeth Corp | Derivados de azinil-3-sulfonilindazol como ligandos de 5-hidroxitriptamina-6. |
| WO2007117413A1 (en) * | 2006-04-05 | 2007-10-18 | Wyeth | Sulfonyl-3-heterocyclylindazole derivatives as 5-hydroxytryptamine-6 ligands |
| WO2007120596A1 (en) * | 2006-04-12 | 2007-10-25 | Wyeth | DIHYDRO[1,4]DIOXINO[2,3-e]INDAZOLE DERIVATIVES AS 5-HYDROXYTRYPTAMINE-6 LIGANDS |
| JP2009538910A (ja) * | 2006-06-01 | 2009-11-12 | ワイス | ５−ヒドロキシトリプタミン−６リガンドとしての１−スルホニルインダゾリルアミン誘導体および１−スルホニルインダゾリルアミド誘導体 |
| WO2009006267A2 (en) * | 2007-06-28 | 2009-01-08 | Wyeth | N'-(2-halobenzylidene)sulfonylhydrazides as intermediates in the manufacture of arylsulfonylindazoles |
| EP2569301A1 (en) | 2010-05-12 | 2013-03-20 | Abbvie Inc. | Indazole inhibitors of kinase |
| EP2624696B1 (en) | 2010-10-06 | 2016-12-21 | Glaxosmithkline LLC | Benzimidazole derivatives as pi3 kinase inhibitors |
| JP6454346B2 (ja) | 2013-12-20 | 2019-01-16 | サンシャイン・レイク・ファーマ・カンパニー・リミテッドＳｕｎｓｈｉｎｅ Ｌａｋｅ Ｐｈａｒｍａ Ｃｏ．，Ｌｔｄ． | 芳香族複素環式化合物及び医薬におけるその応用 |
| CA2953004C (en) | 2014-07-08 | 2023-02-21 | Sunshine Lake Pharma Co., Ltd. | Aromatic heterocyclic derivatives and pharmaceutical applications thereof |
| MY200629A (en) | 2017-08-01 | 2024-01-06 | Theravance Biopharma R&D Ip Llc | Pyrazolo and triazolo bicyclic compounds as jak kinase inhibitors |
| CN113498352A (zh) | 2019-01-23 | 2021-10-12 | 施万生物制药研发Ip有限责任公司 | 作为jak抑制剂的咪唑并[1,5-a]吡啶、1,2,4-三唑并[4,3-a]吡啶和咪唑并[1,5-a]吡嗪 |
| EP4065578A1 (en) | 2019-11-26 | 2022-10-05 | Theravance Biopharma R&D IP, LLC | Fused pyrimidine pyridinone compounds as jak inhibitors |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5274097A (en) * | 1988-04-19 | 1993-12-28 | Bayer Aktiengesellschaft | 1,3-disubstituted pyrrolidines |
| DE3835291A1 (de) | 1988-04-19 | 1989-11-02 | Bayer Ag | 1,3-disubstituierte pyrrolidine |
| GB9103862D0 (en) * | 1991-02-25 | 1991-04-10 | Glaxo Group Ltd | Chemical compounds |
| TW288010B (pl) * | 1992-03-05 | 1996-10-11 | Pfizer | |
| AU7195694A (en) * | 1993-07-19 | 1995-02-20 | Fujisawa Pharmaceutical Co., Ltd. | Benzimidazole derivatives useful as dopamine receptor antagonist, 5-ht receptor agonist or alpha1 receptor antagonist |
| US5578716A (en) * | 1993-12-01 | 1996-11-26 | Mcgill University | DNA methyltransferase antisense oligonucleotides |
| JPH0940646A (ja) | 1995-07-27 | 1997-02-10 | Yamanouchi Pharmaceut Co Ltd | ベンゼン縮合環誘導体又はその塩 |
| GB9523462D0 (en) | 1995-11-16 | 1996-01-17 | Merck Sharp & Dohme | Therapeutic agents |
| AU7526798A (en) * | 1997-04-18 | 1998-11-27 | Smithkline Beecham Plc | Acetamide and urea derivatives, process for their preparation and their use in the treatment of cns disorders |
| AU5960300A (en) * | 1999-07-15 | 2001-02-05 | Nps Allelix Corp. | Heterocyclic compounds for the treatment of migraine |
| JP4307073B2 (ja) * | 2000-12-22 | 2009-08-05 | ワイス | ５−ヒドロキシトリプトアミン−６リガンドとしてのヘテロサイクルインダゾールおよびアザインダゾール化合物 |
| TW593278B (en) * | 2001-01-23 | 2004-06-21 | Wyeth Corp | 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands |
| TW200401641A (en) * | 2002-07-18 | 2004-02-01 | Wyeth Corp | 1-Heterocyclylalkyl-3-sulfonylindole or-indazole derivatives as 5-hydroxytryptamine-6 ligands |
| WO2004074243A2 (en) * | 2003-02-14 | 2004-09-02 | Wyeth | Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands |
-
2002
- 2002-04-19 WO PCT/US2002/012512 patent/WO2002085853A2/en active Application Filing
- 2002-04-19 BR BR0209047-3A patent/BR0209047A/pt not_active IP Right Cessation
- 2002-04-19 CN CNB028123409A patent/CN1293073C/zh not_active Expired - Fee Related
- 2002-04-19 KR KR10-2003-7013584A patent/KR20030088507A/ko not_active Application Discontinuation
- 2002-04-19 EP EP02736592A patent/EP1392682A2/en not_active Withdrawn
- 2002-04-19 AR ARP020101443A patent/AR034588A1/es not_active Application Discontinuation
- 2002-04-19 AU AU2002309585A patent/AU2002309585B2/en not_active Expired - Fee Related
- 2002-04-19 JP JP2002583380A patent/JP2004526781A/ja active Pending
- 2002-04-19 EA EA200301143A patent/EA200301143A1/ru unknown
- 2002-04-19 MX MXPA03009490A patent/MXPA03009490A/es active IP Right Grant
- 2002-04-19 PL PL02366639A patent/PL366639A1/pl unknown
- 2002-04-19 CA CA002444036A patent/CA2444036A1/en not_active Abandoned
- 2002-04-19 HU HU0303801A patent/HUP0303801A2/hu unknown
- 2002-04-19 US US10/126,805 patent/US6831094B2/en not_active Expired - Fee Related
- 2002-04-19 IL IL15844802A patent/IL158448A0/xx unknown
-
2003
- 2003-10-17 NO NO20034647A patent/NO20034647L/no not_active Application Discontinuation
- 2003-11-19 ZA ZA200309009A patent/ZA200309009B/en unknown
-
2004
- 2004-09-24 US US10/949,061 patent/US20050065185A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0303801A2 (hu) | 2004-03-01 |
| WO2002085853A3 (en) | 2002-12-19 |
| US20030078286A1 (en) | 2003-04-24 |
| CA2444036A1 (en) | 2002-10-31 |
| CN1518548A (zh) | 2004-08-04 |
| NO20034647D0 (no) | 2003-10-17 |
| EA200301143A1 (ru) | 2004-02-26 |
| US20050065185A1 (en) | 2005-03-24 |
| CN1293073C (zh) | 2007-01-03 |
| US6831094B2 (en) | 2004-12-14 |
| JP2004526781A (ja) | 2004-09-02 |
| KR20030088507A (ko) | 2003-11-19 |
| AR034588A1 (es) | 2004-03-03 |
| WO2002085853A2 (en) | 2002-10-31 |
| EP1392682A2 (en) | 2004-03-03 |
| ZA200309009B (en) | 2005-02-21 |
| MXPA03009490A (es) | 2004-02-12 |
| BR0209047A (pt) | 2004-08-10 |
| IL158448A0 (en) | 2004-05-12 |
| NO20034647L (no) | 2003-11-20 |
| AU2002309585B2 (en) | 2008-01-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL157059A0 (en) | 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands | |
| IL158445A0 (en) | Heterocyclyloxy-, -thioxy-and-aminobenzazole derivatives as 5-hydroxytryptamine-6 ligands | |
| ZA200500437B (en) | 1-heterocyclyalkyl-3-sulfonazaindole or -azaindazole derivatives as 5-hydroxytryptamine-6 ligands | |
| PL370890A1 (pl) | Pochodne azaindoliloalkiloaminy jako ligandy receptora 5-hydroksytryptaminy-6 | |
| IL155443A0 (en) | 1- aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands | |
| ZA200500435B (en) | 1-heterocyclyalkyl-3-sulfonylindole or -indazole derivatves as 5-hydroxytryptamine-6 ligands | |
| HK1066218A1 (en) | Qunazoline derivatives as antitumor agents | |
| IL162243A0 (en) | Indolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands | |
| ZA200506416B (en) | Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands | |
| IL156517A0 (en) | Heterocyclindazole and azaindazole compounds as 5-hydroxytryptamine-6 ligands | |
| IL160701A0 (en) | 3-substituted-4-pyrimidone derivatives | |
| IL156518A0 (en) | Heteocyclylalkylindole or-azaindole compounds as 5-hydroxytryptamine-6 ligands | |
| IL158448A0 (en) | Heterocyclylalkoxy- alkylthio-and-alkylaminobenzazole derivatives as 5-hydroxytryptamine-6 ligands | |
| HK1068607A1 (en) | Phenylalkyloxy-phenyl derivatives | |
| HUP0303186A3 (en) | 4-aminobenzopyran derivatives | |
| HUP0401949A3 (en) | 4-imidazolin-2-one derivatives | |
| HUP0500026A3 (en) | N-heteroarylnicotinamide derivatives | |
| AU2003209114A1 (en) | Pyrrolylalkylidene-hydrazinecarboximidamide derivatives as 5-hydroxytryptamine-6 ligands | |
| EP1364954A4 (en) | Dicarba closo DODECARBORANDERIVATE | |
| GB0115841D0 (en) | Ligand | |
| AU2002334722A1 (en) | Chroman derivatives as 5-hydroxytryptamine-6 ligands | |
| SI1427709T1 (sl) | 3-substituirani-4-pirimidonski derivati |